Wolverine Trading’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Wolverine Trading’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-40	Closed	-$11K	–	5206
2019 Q2	$11K	Buy	+40	New	+$13.4K	﹤0.01%	4309
2018 Q3	–	Sell	-137	Closed	-$63K	–	6122
2018 Q2	$63K	Hold	137	–	–	﹤0.01%	4855
2018 Q1	$63K	Buy	137 +66	+93%	+$32.8K	﹤0.01%	4855
2017 Q4	$41K	Buy	+71	New	+$46.8K	﹤0.01%	4637
2017 Q3	–	Sell	-34	Closed	-$29K	–	5208
2017 Q2	$29K	Buy	+34	New	+$24.9K	﹤0.01%	4130
2016 Q3	–	Sell	-50	Closed	-$72K	–	5238
2016 Q2	$72K	Buy	+50	New	+$64.3K	﹤0.01%	3735

Other funds holding FRTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Trading's FRTX Position: Q3 2016 in Review

Wolverine Trading sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2016, closing a stake of 32 shares — an estimated $46K sold.

Wolverine Trading first reported a position in FRTX in Q2 2016 and held it in 1 quarter. The position peaked at $46K in Q2 2016. 36 funds tracked by Wall St. Rank hold FRTX as of Q3 2016.

Wolverine Trading reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
Wolverine Trading sold 32 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2016, an estimated $46K.
Wolverine Trading first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2016 and held it in 1 quarter.
Wolverine Trading's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $46K in Q2 2016.
36 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2016.

Based on Wolverine Trading's 13F filing for Q3 2016, filed 14 Nov 2016.